| Ytd | -33.41% | |
| 1y | -26.81% |
| Open | 3.08 | Prev Close | 3.00 | Low | 2.98 | High | 3.28 | Mkt Cap | 26.37M |
| Vol | 9.29K | Avg Vol | 40.02K | EPS | -0.89 | P/E | N/A | Forward P/E | -2.65 |
| Beta | 0.91 | Short Ratio | 0.60 | Inst. Own | 19.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 3.92 | 200-d Avg | 4.53 | 1yr Est | 3.15 |
NMTC News
NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.25) per share which missed the
First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) and NeuroOne Medical Technologies
NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Grow
Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have been given
Jones Trading analyst Justin Walsh initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with
NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the an
Aclarion (NASDAQ: ACON - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free
Cannlabs (OTCMKTS:CANL - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free
RIGL, CM and NMTC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 6th, 202
ILPT, NMTC, RIGL, RIO and BHP have been added to the Zacks Rank #1 (Strong Buy) List on January 6th,
NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.04) per share which met the ana
NeuroOne Medical Technologies Corporation - Special Call Company Participants David Rosa - President
Preliminary Results On October 6, 2024, the Company reported the following preliminary unaudited fi
Maxim Group analyst Anthony Vendetti initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) wi
EDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (N
NeuroOne stock rallies after FDA clears its OneRF system, a minimally invasive solution targeting se
FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and In
Protalix BioTherapeutics, Inc. (PLX) Q3 2025 Earnings Call August 14, 2025 8:30 AM ET Company Partic
NeuroOne Medical Tech (NASDAQ:NMTC) affirms FY2025 sales outlook from $8.00 million-$10.00 million t
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the an
Completed Oversubscribed $8.2 Million Capital Raise; Funded Through At Least Fiscal Year 2026 EDEN P
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NA
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NA
Patent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRI
Patient Treated with OneRF® Ablation System Previously Experienced up to 10 Seizures a DayEDEN PRAIR
Patient Treated with OneRF ® Ablation System Previously Experienced up to 10 Seizures a Day EDEN PRA
NeuroOne Medical Tech (NASDAQ:NMTC) affirms FY2025 sales outlook from $8.00 million-$10.00 million t
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.07) per share. This is a 36.36
Ladenburg Thalmann analyst Jeff Cohen initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) w
Multi-Contact Probe Provides Alternative to Pharmaceutical and Invasive Surgical TreatmentsSubmissio
NeuroOne submits FDA filing early for trigeminal nerve ablation using its OneRF system as the facial